A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis

Keyphrases

• Therapeutic Effect 100%
• Mouse Model 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Cannabidiol 100%
• Encephalomyelitis 100%
• Paralysis 15%
• Multiple Sclerosis 15%
• Spleen Tissue 15%
• Spinal Cord Tissue 15%
• Hindlimb 15%
• Apoptosis 7%
• Tyrosine 7%
• Cannabis Sativa 7%
• C57BL 7%
• Interleukin-10 7%
• Western Blot Analysis 7%
• Nave 7%
• Forkhead Box P3 (FOXP3) 7%
• Neuroprotective Effect 7%
• Induced Damage 7%
• Immunohistochemistry 7%
• Glycoprotein 7%
• Positive Staining 7%
• CD8+ T Cells 7%
• Multiple Sclerosis Treatment 7%
• Conventional Therapy 7%
• Oxidative Damage 7%
• Immunization 7%
• P-selectin 7%
• Myelin 7%
• Lymphocyte Infiltration 7%
• Weight Loss 7%
• Inflammatory Cytokines 7%
• Autoimmune Encephalitis 7%
• Histological Evaluation 7%
• CD4 T Cells 7%
• Inducible Nitric Oxide Synthase 7%
• Clinical Disease 7%
• Daily Treatment 7%
• Clinical Management 7%
• Demyelination 7%
• Histological Score 7%
• Disease Onset 7%
• Topical Treatment 7%
• Inflammation Markers 7%
• Indirect Markers 7%
• Propylene 7%
• Cleaved caspase-3 7%
• MOG35-55 7%
• Disease Score 7%
• Non-psychoactive Cannabinoids 7%
• Associated Symptoms 7%
• Oligodendroglial 7%
• Tissue Localization 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse Model 100%
• Therapeutic Effect 100%
• Cannabidiol 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Encephalomyelitis 100%
• Multiple Sclerosis 23%
• Diseases 23%
• Paralysis 15%
• Western Blot 7%
• Cytokine 7%
• Neuroprotective Agent 7%
• Inflammation 7%
• Caspase 3 7%
• CD8 Antigen 7%
• Psychotropic Agent 7%
• Demyelination 7%
• Interleukin 10 7%
• C57BL 6 Mouse 7%
• Cannabis Sativa 7%
• Selectin (Glycoprotein) 7%
• Propylene 7%
• Myelin Oligodendrocyte Glycoprotein 7%
• Allergic Encephalomyelitis 7%
• 3 Nitrotyrosine 7%
• Lymphocytic Infiltration 7%
• Cannabinoid 7%

Medicine and Dentistry

• Therapy Effect 100%
• Cannabidiol 100%
• Encephalomyelitis 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Diseases 23%
• Multiple Sclerosis 15%
• Paralysis 15%
• Hindlimb 15%
• Spleen Tissue 15%
• Cannabis 7%
• Programmed Cell Death 7%
• Interleukin 10 7%
• Western Blot 7%
• Immunohistochemistry 7%
• Caspase 3 7%
• PADGEM Protein 7%
• Lymphocytic Infiltration 7%
• Symptomatic Treatment 7%
• Neuroprotective Agent 7%
• T-Helper Cell 7%
• Clinical Management 7%
• Cytotoxic T-Cell 7%
• Demyelination 7%
• C57BL/6 7%
• Topical Treatment 7%
• Inflammatory Cytokine 7%
• Treatment of Multiple Sclerosis 7%
• Poly ADP Ribose Polymerase 7%
• Propene 7%
• Myelin Oligodendrocyte Glycoprotein 7%
• Allergic Encephalomyelitis 7%
• 3 Nitrotyrosine 7%
• Cannabinoid 7%